Evaluation of health related quality of life in children with immune thrombocytopenia with the PedsQLTM 4.0 Generic core scales: a study on behalf of the pays de Loire pediatric hematology network. - Archive ouverte HAL Access content directly
Journal Articles Health and Quality of Life Outcomes Year : 2013

Evaluation of health related quality of life in children with immune thrombocytopenia with the PedsQLTM 4.0 Generic core scales: a study on behalf of the pays de Loire pediatric hematology network.

(1) , (2, 3) , (4) , (5) , (1) , (1) , (2) , (6) , (7) , (8) , (9) , (10) , (11) , (2) , (12) , (2, 13)
1
2
3
4
5
6
7
8
9
10
11
12
13
Eliane Tarral
  • Function : Author
  • PersonId : 948466
Christophe Savagner
  • Function : Author
  • PersonId : 948467
Sylvaine Poignant
  • Function : Author
  • PersonId : 948471
Arnaud Boutet
  • Function : Author
  • PersonId : 948472
Joachim Bassil
  • Function : Author
  • PersonId : 948473
Dominique Médinger
  • Function : Author
  • PersonId : 948474
Emmanuel Quemener
  • Function : Author
  • PersonId : 948475
Nancy Young
  • Function : Author
  • PersonId : 948476
Robert Klaassen
  • Function : Author
  • PersonId : 948478

Abstract

BACKGROUND: Immune thrombocytopenia (ITP) is a childhood disorder that is often life-altering for children and their parents. Health related quality of life (HRQL) has never been chronologically monitored in children with ITP. We initiated a prospective study to assess HRQL from diagnosis to six months and define factors that influence this outcome in children with ITP. METHODS: 73 children with acute ITP aged from 2 to 18 years were prospectively enrolled in the study. According to the presence of bleeding, they were or were not given a 4-day course of corticosteroid treatment. The PedsQLTM 4.0 Generic Core Scale was completed by children and parents upon their inclusion in the study and 6 months after diagnosis. RESULTS: Over the six month period, quality of life improved in terms of their global, physical and psychosocial well-being for 54.5 %, 35.6 % and 36.2 % of patients respectively. This improvement is clinically relevant compared to scores at diagnosis, corresponding at least to a minimal clinically important difference (MCID). Factors such as sex, age, platelet count, bleeding scores, bone marrow aspiration and persistence of ITP at 6 months were not significantly associated with HRQL scores. However, preceding viral infection was identified to have an impact on HRQL. CONCLUSIONS: This first longitudinal study assessing HRQL in children with ITP reveals a global improvement in PedSQLTM 4.0. However, these results should be considered with caution since our data also confirm that self-report HRQL scores are not influenced by any analyzed biologic or clinical parameters. Others tools, such as Kids' ITP Tools, would probably be required to assess the HRQL of this population.Trial registration: Trial registration clinical trials.gov Identifier: NCT00331357.
Fichier principal
Vignette du fichier
1477-7525-11-193.pdf (197.78 Ko) Télécharger le fichier
Vignette du fichier
1477-7525-11-193.xml (131.73 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other
Loading...

Dates and versions

inserm-00905117 , version 1 (16-11-2013)

Identifiers

Cite

Marion Strullu, Josué Rakotonjanahary, Eliane Tarral, Christophe Savagner, Caroline Thomas, et al.. Evaluation of health related quality of life in children with immune thrombocytopenia with the PedsQLTM 4.0 Generic core scales: a study on behalf of the pays de Loire pediatric hematology network.. Health and Quality of Life Outcomes, 2013, 11 (1), pp.193. ⟨10.1186/1477-7525-11-193⟩. ⟨inserm-00905117⟩
260 View
168 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More